摘要
心脏及心脑血管疾病是发达国家人群的第一死因,也是中国人死亡的首位原因.L-型钙通道是目前临床上主要使用选择性钙通道阻滞剂1,4-二氢吡啶类药物.文章研究了在非均相催化剂离子交换树脂Amberlyst 15的催化以及无溶剂条件下,高效的合成了钙通道阻滞剂1,4-二氢吡啶类药物.该反应体系具有原料便宜、反应时间短、操作及后处理简单、催化剂可回收利用、反应可放大等优良特点.
Heart and cardio cerebral vascular disease is the first cause of death in developed countries,and also the first cause of death in China.L-type Calcium channel is a kind of 1,4-dihydropyridine drugs,which are mainly used as selective calcium channel blockers in clinic.An efficient protocol has been developed to synthesize various 1,4-dihydropyridines derivatives using commercially available Amberlyst-15 as a catalyst under solvent-free condition.This process has many merits,such as commercially available catalysts with low cost,quite broad substrate scope,high yields,large-scale preparation,environmental friendliness,easy recovery,and simple work-up procedure.
作者
谢建武
刘俊男
谢玄升
XIE Jian-wu;LIU Jun-nan;XIE Xuan-sheng(School of Biological and Pharmaceutical Sciences,Shaanxi University of Science&Technology,Xi′an 710021,China)
出处
《陕西科技大学学报》
北大核心
2024年第1期65-72,共8页
Journal of Shaanxi University of Science & Technology
基金
国家自然科学基金项目(21272214)。
关键词
药物合成
钙通道阻滞剂
1
4-二氢吡啶
绿色合成
非均相催化
pharmaceutical synthesis
calcium channel blockers
1,4-dihydropyridines
green synthesis
heterogeneous catalysis